• Biomerica launched inFoods IBS in Canada through partnerships with Phoenix Airmid Biomedical, exclusive distributor, plus CanAlt Health Labs, certified lab processing partner.
• Phoenix Airmid will run distribution, physician outreach, commercial sales across Canada.
• CanAlt will process inFoods IBS tests, deliver results to physicians, naturopathic doctors, patients nationwide.
• Move marks Biomerica first commercial entry into Canada for its diagnostic-guided therapy platform.
• Biomerica cited IBS prevalence of about 18% in Canada, up to 5 million potential patients.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biomerica Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604140819PRIMZONEFULLFEED9689227) on April 14, 2026, and is solely responsible for the information contained therein.